| Stage | UTI | % of rev | COCO | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $219M | 100.00% | $244M | 100.00% | COCO ×1.11 |
| Gross profit | $219M | 100.00% | $93M | 38.01% | UTI +62.0pp |
| Operating income | $3M | 1.48% | $45M | 18.64% | COCO +17.2pp |
| Pre-tax income | $3M | 1.42% | $44M | 17.89% | COCO +16.5pp |
| Net income | $2M | 1.04% | $35M | 14.36% | COCO +13.3pp |
| Stage | UTI | COCO | Gap · A − B |
|---|---|---|---|
| Revenue | $219M100.00% | $244M100.00% | COCO ×1.11 |
| Gross profit | 100.00%$219M | 38.01%$93M | UTI +62.0pp |
| Operating income | 1.48%$3M | 18.64%$45M | COCO +17.2pp |
| Pre-tax income | 1.42%$3M | 17.89%$44M | COCO +16.5pp |
| Net income |
| 1.04%$2M |
| 14.36%$35M |
| COCO +13.3pp |
No shared counterparties.